Vimarsana
Biggest News Aggregation in the World

Page 16 - Peter Loftus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Loftus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Loftus Today - Breaking & Trending Today

J&J Covid-19 Vaccine Authorized for Use in U.S. -- Update - Vimarsana News

J&J Covid-19 Vaccine Authorized for Use in U.S. -- Update

By Peter Loftus and Thomas M. Burton The first single-dose Covid-19 vaccine, a shot from Johnson & Johnson, was authorized for use, a big boost for a mass-vaccination campaign rushing to... | March 4, 2021

Moderna Says New Variant Vaccine Is Ready for Human Testing - Vimarsana News

Moderna Says New Variant Vaccine Is Ready for Human Testing

The biotech company has sent the NIH a first batch of doses of its newly designed shot that targets the coronavirus strain first identified in South Africa.

Source: msn.com
FDA Says Johnson & Johnson's Covid Vaccine Has a 'Favorable Safety Profile' - Vimarsana News

FDA Says Johnson & Johnson's Covid Vaccine Has a 'Favorable Safety Profile'

The U.S. Food and Drug Administration said Johnson & Johnson’s single-dose Covid-19 vaccine works safely, paving the way for the approval of a third vaccine in the U.S. as early as this weekend.

Source: msn.com
J&J's Covid-19 Vaccine Is Safe and Effective, FDA Says - Vimarsana News

J&J's Covid-19 Vaccine Is Safe and Effective, FDA Says

The U.S. Food and Drug Administration said Johnson & Johnson’s single-dose Covid-19 vaccine works safely, paving the way for the approval of a third vaccine in the U.S. as early as this weekend.

Source: msn.com
J&J Covid-19 Vaccine Was 66% Effective in Late-Stage Study - Vimarsana News

J&J Covid-19 Vaccine Was 66% Effective in Late-Stage Study

By Peter Loftus Johnson & Johnson said its experimental Covid-19 vaccine was 66% effective at protecting people from moderate to severe disease in a large clinical trial, positive results... | February 4, 2021